Company responds to sale rumours

 Posted 1 April 2026 AM

Italian pharma Recordati Rare Disease has been forced to respond to swirling speculation that the company is being sold - admitting there is in fact an offer on the table.

In a statement, the company - which is headquartered in Milan but has about 150 offices around the world, including in Australia - said the offer from private equity firm CVC Capital Partners had not yet been reviewed.

To see the whole article please log in.